Role of ischemia-modified albumin in patients with acute decompensated heart failure (Editorial Comment)

References (14)

1. Dekker MS, Mosterd A, van ‘t Hof AW, Hoes AW. Novel biochemical markers in suspected acute coronary syndrome: systematic review and critical appraisal. Heart 2010
2. [CrossRef] 2. Sbarouni E, Georgiadou P, Kremastinos DT, Voudris V. Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol 2008
3. Dominguez-Rodriguez A, Abreu-Gonzalez P. Current role of ischemia-modified albumin in routine clinical practice. Biomarkers 2010
4. [CrossRef] 4. Apple FS. Clinical and analytical review of ischemia-modified albumin measured by the albumin cobalt binding test. Adv Clin Chem 2005
5. [CrossRef] 5. Dusek J, Tichý M, Stásek J, Bis J, Gregor J, Pudil R, Vojácek J. Ischemia-modified albumin: new marker of myocardial ischemia? Cas Lek Cesk 2005
6. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - review and clinical implications. Clin Chem Lab Med 2011
7. [CrossRef] 7. Çavuşoğlu Y, Korkmaz Ş, Demirtaş S, Gencer E, Şaşmaz H, Mutlu F, et al. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study. Anatol J Cardiol 2015
8. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Samimi-Fard S, Kaski JC. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Chim Acta 2008
9. [CrossRef] 9. Sacchetti A. “Ischemia modified albumin”: a new biochemical marker of myocardial ischaemia. Emerg Med J 2004
10. [CrossRef] 10. Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005
11. [CrossRef] 11. Montagnana M, Lippi G, Fava C, Minuz P, Santonastaso CL, Arosio E, et al. Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease. Clin Chem Lab Med 2006
12. [CrossRef] 12. Van Belle E, Dallongeville J, Vicaut E, Degrandsart A, Baulac C, Montalescot G
13. OPERA Investigators. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. Am Heart SCI 2009
14. [CrossRef] 13. Ell